Gene therapy biotech secures FDA alignment for Huntington's disease BLA submission.

Investing.com -- Texas Precious Metals remains bullish on gold and silver despite recent price weakness, viewing the current pullback as an opportunity for investors to accumulate positions as strong central bank buying and growing retail demand continue to underpin the market, a company executive said.

If approved, uniQure’s AMT-130 would be the first disease-modifying treatment for the inherited neurodegenerative disorder.

Founder Corrado Brondi sat down with WWD to outline the evolution and next strategies of the beauty group, which grew tenfold over the last five years and is poised to hit the 450-million-euro milestone in sales in 2026.

Europe's rearmament pledges sent investors rushing into European defense funds, but the contracts landed somewhere else entirely, and the performance gap between two nearly identical bets tells the story.

Saab AB (SAABF) reports a robust quarter with significant contract wins, improved margins, and increased R&D investments, despite challenges in the Naval business area.

GE Aerospace has completed the world's first high-altitude hybrid-electric test flight while simultaneously securing a major deal with Philippine Airlines for GEnx-1B engines.

Saab’s share price has delivered a very large 5 year gain, yet the stock currently screens as overvalued on market multiples and scores poorly on broader valuation checks, which raises the question of how much of the recent contract momentum is already reflected in today’s price. Over the past 5 years, Saab has returned very roughly 8x for shareholders, which sets a high bar for any further upside from here. Large long term defense contracts and a record order backlog can support revenue...

In recent days, Saab reported second-quarter 2026 results showing higher sales and earnings, while also securing an approximately SEK 8.70 billion contract to equip German MEKO A-200 DEU frigates and deepening its Gripen-related collaboration with CAE in Canada and abroad. Together with the record submarine order backlog and NATO’s selection of Saab’s GlobalEye platform, these developments underline Saab’s expanding role across air and naval defense programs and its growing pipeline of...

Saab (OM:SAAB B) is back in focus after a new Memorandum of Understanding with CAE to collaborate on Gripen training and mission support in Canada, paired with fresh second quarter 2026 earnings. See our latest analysis for Saab. Those earnings and defence contract wins have coincided with a sharp 1 day share price return of 9.73% to SEK567.0. However, Saab's 90 day share price return is down 4.8%, while its 5 year total shareholder return is very large, suggesting long term momentum with...